Abstract:Objective To investigate the effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine. Methods ①AsPC-1 cells transfected with Plk-1 overexpression plasmid(pcDNA/ Plk-1) was selected as treatment group,and empty vector(pcDNA3.1) was selected as control group,total RNA and total protein were extracted,AsPC-1 cells without any treatment was selected as blank group. The RT-PCR and western blotting assay were performed to detect the expression of Plk-1 gene and protein level in AsPC-1 cells after transfection with pcDNA/Plk-1 for 24 hours. ②Flow cytometry assay was used to detect the cell apoptosis change after treatment. ③MTT assays were used to test the effect of different concentration of gemcitabine on proliferation of transfected AsPC-1 cells. Results ①The expression level of Plk-1 mRNA in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(2.14±0.16),(2.18±0.15),(2.58±0.18); the Plk-1 mRNA in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P < 0.01). According to Western blot results,the protein expression level of Plk-1 in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(0.989±0.018),(1.022±0.021),(1.243±0.143),the protein expression level of Plk-1 in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P < 0.01). ②Under the function of Gemcitabine,apoptosis rate in pcDNA3.1/Plk-1 transfection group was lower than that in nontransfection group and empty vector transfection group,the differences were statistically significant(P < 0.01). ③The inhibition proliferation rate of AsPC-1 cells of pcDNA3.1/ Plk-1 transfection group was higher than that of non-transfection group and empty vector transfection group,the differences was statistically significant(P < 0.01). Conclusion Overexpression of Plk-1 gene in AsPC-1 cells can significantly decrease gemcitabine induced apoptosis and increase its chemotherapeutic resistentivity.

Inhibitory Effect of Polo-like Kinase 1 Depletion on Mitosis and Apoptosis of Gastric Cancer Cells

Mitosis Arrest Caused by Inhibition of PLK1 Expression in Gastric Cancer MKN45 Cells

[Study of Growth Inhibition of Gastric Cancer Cells by Srna Targeting Polo Like Kinase 1 in Vitro and Vivo].

Inhibition of plk1 Expression Leads to Increased CyclinB/cdc2 Complex Activity in Gastric Cancer Cells

Inhibition of Plk-1 gene expression enhences 5-Fu and CDDP induced apoptosis of gastric cancer cells

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1

The Balance of Polo-like Kinase 1 in Tumorigenesis

Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells.

Polo Like Kinase 1 Expression and Prognostic Value in Gastric Carcinomas

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade*

Significance of Polo Like Kinase1 and Protein Expression in Gastric Carcinomas

Involvement of Polo-like Kinase 1 (plk1) in Quiescence Regulation of Cancer Stem-Like Cells of the Gastric Cancer Cell Lines

Study on folate deficiency and Polo-like kinase 1 (PLK-1) siRNA in synergistically inhibiting the growtho f gsa tric carcinoma cell lines

Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.

Effect of phospholipase D1 on proliferation of pancreatic cancer cells

Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine

Plk1 As A Potential Drug Target in Cancer Therapy

The Anticipating Value of PLK1 for Diagnosis, Progress and Prognosis and Its Prospective Mechanism in Gastric Cancer: a Comprehensive Investigation Based on High-Throughput Data and Immunohistochemical Validation

POLO-LIKE KINASE1 GENE EXPRESSION AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE IN GASTRIC CARCINOMA